GlassScriptPhysician profile
Nishant I Koradia
NPI 1407039530
$19,063.09
in general payments reported to CMS, 2019-2025
33 companies · $2,660 in 2025
The $2,660 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $1,089 · 2021: $2,166 · 2022: $1,987 · 2023: $1,033 · 2024: $8,308 · 2025: $2,660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,516 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,460 · Travel and Lodging: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,516.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,460.00 |
| Travel and Lodging | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,778.65 | 2021-2025 | Verquvo |
| Edwards Lifesciences Corporation | $3,215.72 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abiomed | $2,414.42 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,179.67 | 2019-2025 | General - Therapies |
| Inari Medical, INC. | $972.78 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $675.19 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Abbott Laboratories | $621.14 | 2021-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit, Xience Skypoint |
| E.R. Squibb & Sons, L.L.C. | $591.81 | 2022-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $375.86 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $302.05 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $301.35 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $286.53 | 2020-2021 | |
| Shockwave Medical, INC | $252.62 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $238.52 | 2019-2024 | Xarelto |
| Amgen INC. | $234.85 | 2022-2025 | Repatha, Repatha |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opsens INC. | $232.83 | 2019 | |
| Lantheus Medical Imaging, INC. | $179.48 | 2020-2021 | |
| Heartflow, INC. | $177.00 | 2023-2025 | Ffrct |
| Esperion Therapeutics, INC. | $140.90 | 2020-2021 | |
| Cordis US Corp. | $130.64 | 2024 | Mynx Venous Vcd |
| Stryker Corporation | $120.04 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Cardinal Health 200 LLC | $112.43 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.27 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $87.19 | 2019-2022 | |
| Ekos Corporation | $66.51 | 2019 | |
| Cardiovascular Systems INC. | $54.57 | 2023 | Diamondback Peripheral |
| Argon Medical Devices, INC. | $52.06 | 2020 | |
| Amarin Pharma, INC. | $47.45 | 2020-2021 | |
| Irhythm Technologies, INC. | $41.86 | 2024 | Zio Monitor, Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $28.96 | 2022 | |
| Philips North America LLC | $17.76 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.08 | 2023 | |
| Pfizer INC. | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Koradia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.